BRCA2 mutation carriers presented with DCIS alone in 14% (35/246), whereas BRCA1 mutation carriers presented with DCIS alone in 9% (23/250) (p = 0.0026) [14]. Here, BRCA2 is linked to ductal breast carcinoma in situ.